Twist Bioscience Corporation Restricted Cash, Current
Twist Bioscience Corporation (TWST) had Restricted Cash, Current of $84.00 thousand as of 2020-06-30, per its 10-Q filed 2020-08-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2020-11-27
- 2020-06-30: Restricted Cash, Current $84.00K.
- 2020-03-31: Restricted Cash, Current $83.00K.
- 2019-09-30: Restricted Cash, Current $84.00K.
- 2019-06-30: Restricted Cash, Current $194.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2020-06-30 | $84.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $83.00K 10-Q · filed 2020-05-13 |
| 2019-09-30 | $84.00K 10-K · filed 2020-11-27 |
| 2019-06-30 | $194.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $216.00K 10-Q · filed 2019-05-02 |
| 2018-12-31 | $57.00K 10-Q · filed 2019-02-11 |
| 2018-09-30 | $201.00K 10-K · filed 2020-11-27 |
| 2017-09-30 | $144.00K 10-K · filed 2019-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |